Author:
Arinaga Shinya,Karimine Nobuya,Adachi Masashi,Inoue Hiroshi,Nanbara Shigeru,Asoh Tsukasa,Ueo Hiroaki,Akiyoshi Tsuyoshi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference34 articles.
1. Akiyoshi T, Arinaga S, Karimine N, Inoue H, Abe R, Takamuku K, Watanabe D, Nagamatsu M, Matsuoka H, Ueo H (1990) Effect of recombinant interleukin 2 in combination with mitomycin C or adriamycin on advanced cancer. Proc. Am Assoc Cancer Res 31: 273
2. Akiyoshi T, Arinaga S, Nanbara S, Karimine N, Inoue H, Takamuku K, Abe R, Watanabe D, Nagamatsu M, Matsuoka H, Ueo H (1990) The effect of interleukin 2 in combination with mitomycin C on advanced cancer. Jpn. J Surg 20: 365
3. Arinaga S, Karimine, N, Takamuku K, Nanbara S, Inoue H, Abe R, Watanabe D, Matsuoka H, Ueo H, Akiyoshi T (1992) Correlation of eosinophila with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C. Cancer Immunol Immunother 35: 246
4. Blay J-Y, Favrot MC, Negrier S, Cambaret V, Chouaib S, Mercatellow A, Maemmerlen P, Franks CR, Philip T (1990) Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor. Cancer Res 50: 2371
5. Caligiuri MA, Murray C, Soiffer RJ, Klumpp TR, Seiden M, Cochran K, Cameron C, Ish C, Buchanan L, Perillo D, Smith K Ritz J (1991). Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity. J Clin Oncol 9: 2110
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献